![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Minimum Supervision Levels Required for Pediatric Cardiology Fellowship Graduation by Pediatric Cardiology Fellowship Program Directors
Entrustable professional activities (EPAs) are “observable essential tasks expected to be performed by a physician for safe patient care in practice.” Six Pediatric Cardiology (PC) EPAs and their level of supe...
-
Article
3D-Printed Cardiac Models for Fetal Counseling: A Pilot Study and Novel Approach to Improve Communication
A fetal cardiology consultation involves using two-dimensional drawings to explain the cardiac anatomy which can result in inherent variation in how the congenital heart disease (CHD) is conveyed. In this pilo...
-
Article
Loss of Consciousness in the Young Child
In the very young child (less than eight years of age), transient loss of consciousness represents a diagnostic and management dilemma for clinicians. While most commonly benign, syncope may be due to cardiac ...
-
Article
Role of a Pediatric Cardiologist in the COVID-19 Pandemic
Coronavirus disease 2019 (COVID-19) has affected patients across all age groups, with a wide range of illness severity from asymptomatic carriers to severe multi-organ dysfunction and death. Although early rep...
-
Article
Utility of 3D Printed Cardiac Models for Medical Student Education in Congenital Heart Disease: Across a Spectrum of Disease Severity
The most common modes of medical education for congenital heart disease (CHD) rely heavily on 2-dimensional imaging. Three-dimensional (3D) printing technology allows for the creation of physical cardiac model...
-
Article
Congenital heart block in neonatal lupus: The pediatric cardiologist’s perspective
Clinical presentation. Congenital heart block (CHB) in the absence of major structural abnormalities is associated with maternal antibodies to Ro (SS-A) and La (SS-B). CHB is most commonly diagnosed between 18 an...
-
Article
SAFETY ASPECTS OF GH THERAPY IN TURNER SYNDROME (TS): NO EVIDENCE FOR VENTRICULAR HYPERTROPHY (VH) AND NORMALIZATION OF INSULIN LEVELS AFTER DISCONTINUATION OF GH. 572